Author | Missak Haigentz, MD | OncLive

Author | Missak Haigentz, MD

Articles

Dr. Haigentz on the Potential of Erlotinib and Bevacizumab in EGFR-Mutant NSCLC

November 17, 2018

Video

Missak Haigentz, MD, chief of Hematology and Oncology at Morristown Medical Center and medical director of Atlantic Hematology and Oncology for Atlantic Medical Group at the Carol G. Simon Cancer Center, discusses the potential of erlotinib (Tarceva) and bevacizumab (Avastin) in EGFR-mutant non–small cell lung cancer (NSCLC).

Dr. Haigentz on the Impact of Immunotherapy in Head and Neck Cancer

September 20, 2018

Video

Missak Haigentz, MD, chief of Hematology and Oncology at Morristown Medical Center, medical director of Atlantic Hematology and Oncology for Atlantic Medical Group at the Carol G. Simon Cancer Center, discusses the impact that immunotherapy has had on the treatment of patients with head and neck cancer.

x